Bio: Tolulope Bolarinwa is a biopharma researcher and chemist with expertise in cancer drug discovery, diagnostics, and quality systems. He has authored and co-authored over 15 peer-reviewed publications in leading journals and serves on multiple editorial boards while reviewing extensively for international scientific outlets. Currently a Medical Technologist at LabCorp CLS, he contributes to drug development by designing and validating clinical assays for investigational therapies. His previous research at Western Illinois University advanced novel transition-metal chemotherapy agents and cytotoxicity assays. Recognized globally, Tolulope is also active in mentoring young scientists, judging international competitions, and fostering innovation in global healthcare.